This inflammation of the colon poses a substantial burden to patients and the health care system.
Patient fears can be mitigated by pharmacists who use targeted communication strategies to bolster acceptance.
When helping individuals prepare for travel, pharmacists must make travel health recommendations and know common travel-related immunizations and additional resources.
Pharmacists play a vital role in HIV care by addressing social determinants of health, managing complex HIV medication regimens, and providing comprehensive patient counseling.
A patient with BPDCN finds her champion.
The combination of loop diuretics with other drugs that act at different pharmacologic targets has been shown to improve diuretic response in patients with heart failure.
This article reviews the efficacy and safety data for bispecific T-cell engagers and the practical considerations for their implementation across various types of practice sites for the historically difficult-to-treat relapsed/refractory B-cell lymphoma population.
Closing out their discussion on Clostridioides difficile infection, panelists share closing thoughts on novel pipeline therapies.
Pharmacists should get involved in all the various aspects of their business and with the different professional groups available.
Investigators assessed the efficacy of BsAb5003 in treating multiple myeloma, with the results showing that the therapy may be an effective treatment approach.
Treatment often involves a combination of preventive measures, topical therapies, and systemic treatments.
An increase in the use of GLP-1 agonists for weight loss is affecting patients with diabetes who rely on these medications.
The hybrid pharmacy model represents a significant step forward in providing the best possible care for individuals struggling with behavioral health conditions, ultimately improving their outcomes and overall well-being.
Confusing product labeling and conflicting data can create challenges for patients.
For more than 30 years, there has been little treatment advancement for NMIBC patients. Fortunately, a new development in the treatment of NMIBC has been approved by the FDA and is now available.
Empathy is being left outside the exam room door.
Non–FDA-approved medications may be accessed for patient care via 3 alternative pathways: expanded access, the Right to Try Act, and off-label use, which are reviewed in this article.
Intranasal decongestants are preferred alternatives to oral phenylephrine for relief of nasal congestion.
Pharmacists play a key role in the management of modern monoclonal antibody treatments for Alzheimer disease.
Trisha Winroth, PharmD, and Ashly McPhillips, PharmD, discuss how the shingles vaccine works to prevent reactivation of the varicella-zoster virus and reduce shingles risk, and how to effectively address patient concerns and misconceptions about the vaccine’s benefits, symptoms, and complications of shingles.
The future of vancomycin dosing lies in optimizing dosing regimens to individual patient needs.
An increase in the use of GLP-1 agonists for weight loss is affecting patients with diabetes who rely on these medications.
This quality improvement initiative demonstrates that pharmacies were unable to use performance reports provided by the payer to improve performance scores and decrease direct and indirect remuneration (DIR) fees.
This short story, illustrated by Roth, portrays pharmacists in a variety of settings and was written with the intent to introduce the career in a fun and understandable way for children and inspire kids to pursue their dreams.
True patient centricity treats the whole patient and places an emphasis on broader patient engagement and satisfaction.
Pharmacists, who play a crucial role at the intersection of prescribing and dispensing, are well-positioned to influence these disparities.
Systemic treatment options have historically been limited to traditional chemotherapy agents.
Pharmacy teams are learning to adapt to the challenges of limited distribution networks and orphan drug designation in oncology, with integrated pharmacy support playing a crucial role in enhancing patient access and adherence.
Indications for adalimumab include ankylosing spondylitis, Crohn disease, chronic plaque psoriasis, juvenile idiopathic arthritis, moderate to severe rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis.
For more than 30 years, there has been little treatment advancement for NMIBC patients. Fortunately, a new development in the treatment of NMIBC has been approved by the FDA and is now available.